U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07008391) titled 'High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS' on May 16.
Brief Summary: The TIGER study is a study investigating the utlility of a point-of-care blood analyse of Troponin I to help identify patients with heart attacks in the prehospital emergency care. The study is conducted within the ambulance services of Region Stockholm and compares standard medical care with and without the addition of this quick test.
Chest pain is one of the most common reasons for ambulance dispatch, but currently only about one-third of heart attacks are detected before arriving at the hospital-mainly through ECG. The remaining two...